USPTO serial 79288536
CINCLUS PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 9, 2021
- Examiner
- SALCIDO, JOHN CHARLES
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CINCLUS PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles P. Guarino
Charles P. Guarino Moser Taboada1030 Broad Street - Suite 203Shrewsbury, NJ 07702UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; Medicinal preparations and substances for gastrointestinal diseases and disorders; Pharmaceuticals for the treatment of gastrointestinal diseases and disorders; Pharmaceutical preparations for treating gastrointestinal diseases and disorders; Medicines for the treatment of gastrointestinal diseases and disorders | ACTIVE | — |
| 042 | Development of pharmaceutical preparations and medicines; pharmaceutical drug development services; scientific research in the field of pharmacy; scientific research and development; pharmaceutical products development; medical research | ACTIVE | — |
| 044 | Medical services; Healthcare advisory services in the field of medical treatment, wellness, nutrition; Pharmaceutical advice; Advisory services relating to pharmaceuticals, namely pharmaceutical advice, medical and pharmaceutical consultation; Medical counseling | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cinclus Pharma Holding AB (publ)
- Other trademarks owned by Cinclus Pharma AG
- Other trademarks owned by Cinclus Pharma AG
- Other trademarks owned by Cinclus Pharma AG
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CINCLUS PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 9, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 5, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 16, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 16, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 9, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 9, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 22, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 22, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 2, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 16, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 16, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 16, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 16, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 3, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 14, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 14, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 20, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 19, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 18, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 6, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 2, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |